I agree that this site is using cookies. You can find further informations here.
X
Ratain, Mark J.
385  results:
Search for persons X
?
1

Pharmacogenetic and clinical risk factors for bevacizumab-r..:

Patel, Jai N. ; Jiang, Chen ; Owzar, Kouros...
The Pharmacogenomics Journal.  24 (2024)  2 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Therapeutic Drug Monitoring of Oral Oncology Drugs: Another..:

Ratain, Mark J.
Clinical Pharmacology & Therapeutics.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Common variation in a long non-coding RNA gene modulates va..:

Quintanilha, Julia C.F. ; Sibley, Alexander B. ; Liu, Yingmiao...
BMC Genomics.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
4

Sotorasib dosing and incremental cost ineffectiveness — imp..:

Strohbehn, Garth W. ; Ratain, Mark J.
Nature Reviews Clinical Oncology.  21 (2024)  5 - p. 331-332 , 2024
Link: https://doi.org/10.1038/..
 
?
5

Critical importance of correctly defining and reporting sec..:

Levit, Laura A ; Garrett-Mayer, Elizabeth ; Peppercorn, Jeffrey.
Clinical Trials.  , 2024
Link: https://doi.org/10.1177/..
 
?
6

Interventional pharmacoeconomics for immune checkpoint inhi..:

Wesevich, Austin ; Goldstein, Daniel A. ; Paydary, Koosha...
British Journal of Cancer.  129 (2023)  9 - p. 1389-1396 , 2023
Link: https://doi.org/10.1038/..
 
?
7

In Silico Re‐Optimization of Atezolizumab Dosing Using Popu..:

Peer, Cody J. ; Schmidt, Keith T. ; Arisa, Oluwatobi...
The Journal of Clinical Pharmacology.  63 (2023)  6 - p. 672-680 , 2023
Link: https://doi.org/10.1002/..
 
?
8

Combining atezolizumab 1200 mg with bevacizumab 15 mg/kg: b..:

Ratain, Mark J. ; Strohbehn, Garth W.
European Journal of Cancer.  194 (2023)  - p. 113349 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Do patent applications and Cooperative Research and Develop..:

Wesevich, Austin ; Ratain, Mark J.
Nature Biotechnology.  41 (2023)  11 - p. 1517-1519 , 2023
Link: https://doi.org/10.1038/..
 
?
10

Special designations and the US Food and Drug Administratio..:

Strohbehn, Garth W ; Ratain, Mark J
JNCI: Journal of the National Cancer Institute.  116 (2023)  2 - p. 177-179 , 2023
Link: https://doi.org/10.1093/..
 
?
11

Optimizing the doses of cancer drugs after usual dose findi..:

Strohbehn, Garth W ; Stadler, Walter M ; Boonstra, Philip S.
Clinical Trials.  21 (2023)  3 - p. 340-349 , 2023
Link: https://doi.org/10.1177/..
 
?
12

Implementation of pharmacogenomics into inpatient general m..:

Chen, Thomas ; O'Donnell, Peter H. ; Middlestadt, Merisa...
Pharmacogenetics and Genomics.  33 (2022)  2 - p. 19-23 , 2022
Link: https://doi.org/10.1097/..
 
?
13

The dosing of ibrutinib and related Bruton's tyrosine kinas..:

Ratain, Mark J. ; Tannock, Ian F. ; Lichter, Allen S.
Blood Advances.  6 (2022)  17 - p. 5041-5044 , 2022
Link: https://doi.org/10.1182/..
 
?
14

Two polymorphic gene loci associated with treprostinil dose..:

Thomeas-McEwing, Vasiliki ; Psotka, Mitchell A. ; Gamazon, Eric R....
Pharmacogenetics and Genomics.  32 (2022)  4 - p. 144-151 , 2022
Link: https://doi.org/10.1097/..
 
?
15

Rightsizing the Dosing of Modern Oncology Drugs: Mind the G..:

Ratain, Mark J.
Indian Journal of Medical and Paediatric Oncology.  43 (2022)  3 - p. 304-305 , 2022
Link: https://doi.org/10.1055/..
 
1-15